Renoxtin 5 mg/ml (IV Infusion)
50 mg vial: ৳ 2,900.00
Medicine Details
Category | Details |
---|---|
Generic | Oxaliplatin |
Company | Renata limited |
Indications
- Adjuvant treatment of stage III colon cancer
- Treatment of advanced colorectal cancer
Pharmacology
- Formation of reactive species
- DNA replication and transcription inhibition
- Cell-cycle nonspecific cytotoxicity
- Antitumor activity against colon carcinoma
Dosage & Administration
- Administered in combination with 5-fluorouracil/folinic acid every 2 weeks
- Treatment duration for advanced disease and adjuvant use
- Specific dosage and administration instructions for different days
Interaction
- No specific cytochrome P-450-based drug interaction studies conducted
- Platinum-containing species elimination through the kidney
- Potential nephrotoxic compound coadministration
Contraindications
- Contraindicated in patients with known allergy to oxaliplatin or other platinum compounds
Side Effects
- Peripheral sensory neuropathy
- Neutropenia
- Thrombocytopenia
- Anemia
- Nausea
- Increase in transaminases and alkaline phosphatase
- Diarrhea
- Emesis
- Fatigue
- Stomatitis
- Other reported adverse reactions, including serious ones
Pregnancy & Lactation
- Pregnancy Category D
- Potential fetal harm
- No adequate and well-controlled studies in pregnant women
- Advice for women of childbearing potential
- Unknown excretion in human milk
- Consideration for nursing mothers
Precautions & Warnings
- Grade 3/4 hypersensitivity
- Neurological toxicity monitoring
- Acute laryngopharyngeal dysaesthesias management
- Pulmonary toxicity association
- Hepatotoxicity and liver function test monitoring
- Cardiovascular toxicity including QT prolongation and ventricular arrhythmias
- ECG monitoring recommendations
- Avoidance in patients with congenital long QT syndrome
Overdose Effects
- No known antidote for overdose
- Complications of overdose including hypersensitivity reaction, myelosuppression, nausea, vomiting, diarrhea, and neurotoxicity
- Cases of reported overdoses
- Adverse reactions observed in overdose cases
- Maximum dose administered in a single infusion
Therapeutic Class
- Cytotoxic Chemotherapy
Storage Conditions
- Cool and dry place storage
- Protection from light and moisture
- Keep out of reach of children
Related Brands
- Oxaliplatin PhaRes 5 mg/ml (IV Infusion) - thymoorgan-pharmazie-gmbh-germany
- Oxator 5 mg/ml (IV Infusion) - eskayef-pharmaceuticals-ltd
- Oxaliplat 5 mg/ml (IV Infusion) - healthcare-pharmaceuticals-ltd
- Oxiplat 5 mg/ml (IV Infusion) - drug-international-ltd
- Oxaliplatin AqVida 5 mg/ml (IV Infusion) - aqvida-gmbh